 | • レポートコード：MRC2012B1051 • 出版社/出版日：GlobalInfoResearch / 2020年12月24日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、着床前遺伝子診断（PGD）の世界市場を広く調査・分析し、今後の市場展望をまとめております。着床前遺伝子診断（PGD）の種類別市場規模（性別選択、染色体異常、単一遺伝子障害、HLAタイピング、異数性、X連鎖性疾患、その他）、用途別市場規模（病院、診療所、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Abbott Laboratories、Agilent Technologies、Illumina、Natera, Inc、Laboratory Corporation of America Holdings、PerkinElmer、Cooper Surgical、Thermo Fisher Scientific、F. Hoffmann-La Roche、Quest Diagnostics Incorporated、Beijing Genomics Institute (BGI)、Genea Limited、 ・地域別グローバル市場分析 2015年-2020年 ・着床前遺伝子診断（PGD）の北米市場（アメリカ、カナダ、メキシコ） ・着床前遺伝子診断（PGD）のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・着床前遺伝子診断（PGD）のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・着床前遺伝子診断（PGD）の南米市場（ブラジル、アルゼンチン） ・着床前遺伝子診断（PGD）の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：性別選択、染色体異常、単一遺伝子障害、HLAタイピング、異数性、X連鎖性疾患、その他 ・用途別分析：病院、診療所、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Preimplantation Genetics Diagnosis (PGD) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.4% in the forecast period of 2020 to 2025 and will expected to reach USD 113.2 million by 2025, from USD 99.1 million in 2019.
The Preimplantation Genetics Diagnosis (PGD) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Preimplantation Genetics Diagnosis (PGD) market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Preimplantation Genetics Diagnosis (PGD) market has been segmented into:
Gender Selection
Chromosomal Abnormalities
Single Gene Disorders
HLA Typing
Aneuploidy
X-Linked Diseases
Other
By Application, Preimplantation Genetics Diagnosis (PGD) has been segmented into:
Hospitals
Clinics
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Preimplantation Genetics Diagnosis (PGD) market presented in the report. This section sheds light on the sales growth of different regional and country-level Preimplantation Genetics Diagnosis (PGD) markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Preimplantation Genetics Diagnosis (PGD) market.
The report offers in-depth assessment of the growth and other aspects of the Preimplantation Genetics Diagnosis (PGD) market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Preimplantation Genetics Diagnosis (PGD) Market Share Analysis
Preimplantation Genetics Diagnosis (PGD) competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Preimplantation Genetics Diagnosis (PGD) sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Preimplantation Genetics Diagnosis (PGD) sales, revenue and market share for each player covered in this report.
The major players covered in Preimplantation Genetics Diagnosis (PGD) are:
Abbott Laboratories
Agilent Technologies
Illumina
Natera, Inc
Laboratory Corporation of America Holdings
PerkinElmer
Cooper Surgical
Thermo Fisher Scientific
F. Hoffmann-La Roche
Quest Diagnostics Incorporated
Beijing Genomics Institute (BGI)
Genea Limited
Table of Contents
1 Preimplantation Genetics Diagnosis (PGD) Market Overview
1.1 Product Overview and Scope of Preimplantation Genetics Diagnosis (PGD)
1.2 Classification of Preimplantation Genetics Diagnosis (PGD) by Type
1.2.1 Global Preimplantation Genetics Diagnosis (PGD) Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Preimplantation Genetics Diagnosis (PGD) Revenue Market Share by Type in 2019
1.2.3 Gender Selection
1.2.4 Chromosomal Abnormalities
1.2.5 Single Gene Disorders
1.2.6 HLA Typing
1.2.7 Aneuploidy
1.2.8 X-Linked Diseases
1.2.9 Other
1.3 Global Preimplantation Genetics Diagnosis (PGD) Market by Application
1.3.1 Overview: Global Preimplantation Genetics Diagnosis (PGD) Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Global Preimplantation Genetics Diagnosis (PGD) Market by Regions
1.4.1 Global Preimplantation Genetics Diagnosis (PGD) Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Preimplantation Genetics Diagnosis (PGD) (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Preimplantation Genetics Diagnosis (PGD) Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Preimplantation Genetics Diagnosis (PGD) Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Preimplantation Genetics Diagnosis (PGD) Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Preimplantation Genetics Diagnosis (PGD) Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Preimplantation Genetics Diagnosis (PGD) Status and Prospect (2015-2025)
2 Company Profiles
2.1 Abbott Laboratories
2.1.1 Abbott Laboratories Details
2.1.2 Abbott Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Abbott Laboratories SWOT Analysis
2.1.4 Abbott Laboratories Product and Services
2.1.5 Abbott Laboratories Preimplantation Genetics Diagnosis (PGD) Revenue, Gross Margin and Market Share (2018-2019)
2.2 Agilent Technologies
2.2.1 Agilent Technologies Details
2.2.2 Agilent Technologies Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Agilent Technologies SWOT Analysis
2.2.4 Agilent Technologies Product and Services
2.2.5 Agilent Technologies Preimplantation Genetics Diagnosis (PGD) Revenue, Gross Margin and Market Share (2018-2019)
2.3 Illumina
2.3.1 Illumina Details
2.3.2 Illumina Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Illumina SWOT Analysis
2.3.4 Illumina Product and Services
2.3.5 Illumina Preimplantation Genetics Diagnosis (PGD) Revenue, Gross Margin and Market Share (2018-2019)
2.4 Natera, Inc
2.4.1 Natera, Inc Details
2.4.2 Natera, Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Natera, Inc SWOT Analysis
2.4.4 Natera, Inc Product and Services
2.4.5 Natera, Inc Preimplantation Genetics Diagnosis (PGD) Revenue, Gross Margin and Market Share (2018-2019)
2.5 Laboratory Corporation of America Holdings
2.5.1 Laboratory Corporation of America Holdings Details
2.5.2 Laboratory Corporation of America Holdings Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Laboratory Corporation of America Holdings SWOT Analysis
2.5.4 Laboratory Corporation of America Holdings Product and Services
2.5.5 Laboratory Corporation of America Holdings Preimplantation Genetics Diagnosis (PGD) Revenue, Gross Margin and Market Share (2018-2019)
2.6 PerkinElmer
2.6.1 PerkinElmer Details
2.6.2 PerkinElmer Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 PerkinElmer SWOT Analysis
2.6.4 PerkinElmer Product and Services
2.6.5 PerkinElmer Preimplantation Genetics Diagnosis (PGD) Revenue, Gross Margin and Market Share (2018-2019)
2.7 Cooper Surgical
2.7.1 Cooper Surgical Details
2.7.2 Cooper Surgical Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Cooper Surgical SWOT Analysis
2.7.4 Cooper Surgical Product and Services
2.7.5 Cooper Surgical Preimplantation Genetics Diagnosis (PGD) Revenue, Gross Margin and Market Share (2018-2019)
2.8 Thermo Fisher Scientific
2.8.1 Thermo Fisher Scientific Details
2.8.2 Thermo Fisher Scientific Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Thermo Fisher Scientific SWOT Analysis
2.8.4 Thermo Fisher Scientific Product and Services
2.8.5 Thermo Fisher Scientific Preimplantation Genetics Diagnosis (PGD) Revenue, Gross Margin and Market Share (2018-2019)
2.9 F. Hoffmann-La Roche
2.9.1 F. Hoffmann-La Roche Details
2.9.2 F. Hoffmann-La Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 F. Hoffmann-La Roche SWOT Analysis
2.9.4 F. Hoffmann-La Roche Product and Services
2.9.5 F. Hoffmann-La Roche Preimplantation Genetics Diagnosis (PGD) Revenue, Gross Margin and Market Share (2018-2019)
2.10 Quest Diagnostics Incorporated
2.10.1 Quest Diagnostics Incorporated Details
2.10.2 Quest Diagnostics Incorporated Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Quest Diagnostics Incorporated SWOT Analysis
2.10.4 Quest Diagnostics Incorporated Product and Services
2.10.5 Quest Diagnostics Incorporated Preimplantation Genetics Diagnosis (PGD) Revenue, Gross Margin and Market Share (2018-2019)
2.11 Beijing Genomics Institute (BGI)
2.11.1 Beijing Genomics Institute (BGI) Details
2.11.2 Beijing Genomics Institute (BGI) Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Beijing Genomics Institute (BGI) SWOT Analysis
2.11.4 Beijing Genomics Institute (BGI) Product and Services
2.11.5 Beijing Genomics Institute (BGI) Preimplantation Genetics Diagnosis (PGD) Revenue, Gross Margin and Market Share (2018-2019)
2.12 Genea Limited
2.12.1 Genea Limited Details
2.12.2 Genea Limited Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Genea Limited SWOT Analysis
2.12.4 Genea Limited Product and Services
2.12.5 Genea Limited Preimplantation Genetics Diagnosis (PGD) Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Preimplantation Genetics Diagnosis (PGD) Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Preimplantation Genetics Diagnosis (PGD) Players Market Share
3.2.2 Top 10 Preimplantation Genetics Diagnosis (PGD) Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Preimplantation Genetics Diagnosis (PGD) Revenue and Market Share by Regions
4.2 North America Preimplantation Genetics Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
4.3 Europe Preimplantation Genetics Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
4.5 South America Preimplantation Genetics Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Preimplantation Genetics Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
5 North America Preimplantation Genetics Diagnosis (PGD) Revenue by Countries
5.1 North America Preimplantation Genetics Diagnosis (PGD) Revenue by Countries (2015-2020)
5.2 USA Preimplantation Genetics Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
5.3 Canada Preimplantation Genetics Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
5.4 Mexico Preimplantation Genetics Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
6 Europe Preimplantation Genetics Diagnosis (PGD) Revenue by Countries
6.1 Europe Preimplantation Genetics Diagnosis (PGD) Revenue by Countries (2015-2020)
6.2 Germany Preimplantation Genetics Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
6.3 UK Preimplantation Genetics Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
6.4 France Preimplantation Genetics Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
6.5 Russia Preimplantation Genetics Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
6.6 Italy Preimplantation Genetics Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Revenue by Countries
7.1 Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Revenue by Countries (2015-2020)
7.2 China Preimplantation Genetics Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
7.3 Japan Preimplantation Genetics Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
7.4 Korea Preimplantation Genetics Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
7.5 India Preimplantation Genetics Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Preimplantation Genetics Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
8 South America Preimplantation Genetics Diagnosis (PGD) Revenue by Countries
8.1 South America Preimplantation Genetics Diagnosis (PGD) Revenue by Countries (2015-2020)
8.2 Brazil Preimplantation Genetics Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
8.3 Argentina Preimplantation Genetics Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Preimplantation Genetics Diagnosis (PGD) by Countries
9.1 Middle East & Africa Preimplantation Genetics Diagnosis (PGD) Revenue by Countries (2015-2020)
9.2 Saudi Arabia Preimplantation Genetics Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
9.3 UAE Preimplantation Genetics Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
9.4 Egypt Preimplantation Genetics Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
9.5 South Africa Preimplantation Genetics Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Preimplantation Genetics Diagnosis (PGD) Revenue and Market Share by Type (2015-2020)
10.2 Global Preimplantation Genetics Diagnosis (PGD) Market Forecast by Type (2019-2024)
10.3 Gender Selection Revenue Growth Rate (2015-2025)
10.4 Chromosomal Abnormalities Revenue Growth Rate (2015-2025)
10.5 Single Gene Disorders Revenue Growth Rate (2015-2025)
10.6 HLA Typing Revenue Growth Rate (2015-2025)
10.7 Aneuploidy Revenue Growth Rate (2015-2025)
10.8 X-Linked Diseases Revenue Growth Rate (2015-2025)
10.9 Other Revenue Growth Rate (2015-2025)
11 Global Preimplantation Genetics Diagnosis (PGD) Market Segment by Application
11.1 Global Preimplantation Genetics Diagnosis (PGD) Revenue Market Share by Application (2015-2020)
11.2 Preimplantation Genetics Diagnosis (PGD) Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Clinics Revenue Growth (2015-2020)
11.5 Other Revenue Growth (2015-2020)
12 Global Preimplantation Genetics Diagnosis (PGD) Market Size Forecast (2021-2025)
12.1 Global Preimplantation Genetics Diagnosis (PGD) Market Size Forecast (2021-2025)
12.2 Global Preimplantation Genetics Diagnosis (PGD) Market Forecast by Regions (2021-2025)
12.3 North America Preimplantation Genetics Diagnosis (PGD) Revenue Market Forecast (2021-2025)
12.4 Europe Preimplantation Genetics Diagnosis (PGD) Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Revenue Market Forecast (2021-2025)
12.6 South America Preimplantation Genetics Diagnosis (PGD) Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Preimplantation Genetics Diagnosis (PGD) Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Preimplantation Genetics Diagnosis (PGD) Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Preimplantation Genetics Diagnosis (PGD) by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Preimplantation Genetics Diagnosis (PGD) Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Preimplantation Genetics Diagnosis (PGD) Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Abbott Laboratories Corporate Information, Location and Competitors
Table 6. Abbott Laboratories Preimplantation Genetics Diagnosis (PGD) Major Business
Table 7. Abbott Laboratories Preimplantation Genetics Diagnosis (PGD) Total Revenue (USD Million) (2017-2018)
Table 8. Abbott Laboratories SWOT Analysis
Table 9. Abbott Laboratories Preimplantation Genetics Diagnosis (PGD) Product and Solutions
Table 10. Abbott Laboratories Preimplantation Genetics Diagnosis (PGD) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Agilent Technologies Corporate Information, Location and Competitors
Table 12. Agilent Technologies Preimplantation Genetics Diagnosis (PGD) Major Business
Table 13. Agilent Technologies Preimplantation Genetics Diagnosis (PGD) Total Revenue (USD Million) (2018-2019)
Table 14. Agilent Technologies SWOT Analysis
Table 15. Agilent Technologies Preimplantation Genetics Diagnosis (PGD) Product and Solutions
Table 16. Agilent Technologies Preimplantation Genetics Diagnosis (PGD) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Illumina Corporate Information, Location and Competitors
Table 18. Illumina Preimplantation Genetics Diagnosis (PGD) Major Business
Table 19. Illumina Preimplantation Genetics Diagnosis (PGD) Total Revenue (USD Million) (2017-2018)
Table 20. Illumina SWOT Analysis
Table 21. Illumina Preimplantation Genetics Diagnosis (PGD) Product and Solutions
Table 22. Illumina Preimplantation Genetics Diagnosis (PGD) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Natera, Inc Corporate Information, Location and Competitors
Table 24. Natera, Inc Preimplantation Genetics Diagnosis (PGD) Major Business
Table 25. Natera, Inc Preimplantation Genetics Diagnosis (PGD) Total Revenue (USD Million) (2017-2018)
Table 26. Natera, Inc SWOT Analysis
Table 27. Natera, Inc Preimplantation Genetics Diagnosis (PGD) Product and Solutions
Table 28. Natera, Inc Preimplantation Genetics Diagnosis (PGD) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Laboratory Corporation of America Holdings Corporate Information, Location and Competitors
Table 30. Laboratory Corporation of America Holdings Preimplantation Genetics Diagnosis (PGD) Major Business
Table 31. Laboratory Corporation of America Holdings Preimplantation Genetics Diagnosis (PGD) Total Revenue (USD Million) (2017-2018)
Table 32. Laboratory Corporation of America Holdings SWOT Analysis
Table 33. Laboratory Corporation of America Holdings Preimplantation Genetics Diagnosis (PGD) Product and Solutions
Table 34. Laboratory Corporation of America Holdings Preimplantation Genetics Diagnosis (PGD) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. PerkinElmer Corporate Information, Location and Competitors
Table 36. PerkinElmer Preimplantation Genetics Diagnosis (PGD) Major Business
Table 37. PerkinElmer Preimplantation Genetics Diagnosis (PGD) Total Revenue (USD Million) (2017-2018)
Table 38. PerkinElmer SWOT Analysis
Table 39. PerkinElmer Preimplantation Genetics Diagnosis (PGD) Product and Solutions
Table 40. PerkinElmer Preimplantation Genetics Diagnosis (PGD) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Cooper Surgical Corporate Information, Location and Competitors
Table 42. Cooper Surgical Preimplantation Genetics Diagnosis (PGD) Major Business
Table 43. Cooper Surgical Preimplantation Genetics Diagnosis (PGD) Total Revenue (USD Million) (2017-2018)
Table 44. Cooper Surgical SWOT Analysis
Table 45. Cooper Surgical Preimplantation Genetics Diagnosis (PGD) Product and Solutions
Table 46. Cooper Surgical Preimplantation Genetics Diagnosis (PGD) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Thermo Fisher Scientific Corporate Information, Location and Competitors
Table 48. Thermo Fisher Scientific Preimplantation Genetics Diagnosis (PGD) Major Business
Table 49. Thermo Fisher Scientific Preimplantation Genetics Diagnosis (PGD) Total Revenue (USD Million) (2017-2018)
Table 50. Thermo Fisher Scientific SWOT Analysis
Table 51. Thermo Fisher Scientific Preimplantation Genetics Diagnosis (PGD) Product and Solutions
Table 52. Thermo Fisher Scientific Preimplantation Genetics Diagnosis (PGD) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. F. Hoffmann-La Roche Corporate Information, Location and Competitors
Table 54. F. Hoffmann-La Roche Preimplantation Genetics Diagnosis (PGD) Major Business
Table 55. F. Hoffmann-La Roche Preimplantation Genetics Diagnosis (PGD) Total Revenue (USD Million) (2017-2018)
Table 56. F. Hoffmann-La Roche SWOT Analysis
Table 57. F. Hoffmann-La Roche Preimplantation Genetics Diagnosis (PGD) Product and Solutions
Table 58. F. Hoffmann-La Roche Preimplantation Genetics Diagnosis (PGD) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Quest Diagnostics Incorporated Corporate Information, Location and Competitors
Table 60. Quest Diagnostics Incorporated Preimplantation Genetics Diagnosis (PGD) Major Business
Table 61. Quest Diagnostics Incorporated Preimplantation Genetics Diagnosis (PGD) Total Revenue (USD Million) (2017-2018)
Table 62. Quest Diagnostics Incorporated SWOT Analysis
Table 63. Quest Diagnostics Incorporated Preimplantation Genetics Diagnosis (PGD) Product and Solutions
Table 64. Quest Diagnostics Incorporated Preimplantation Genetics Diagnosis (PGD) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Beijing Genomics Institute (BGI) Corporate Information, Location and Competitors
Table 66. Beijing Genomics Institute (BGI) Preimplantation Genetics Diagnosis (PGD) Major Business
Table 67. Beijing Genomics Institute (BGI) Preimplantation Genetics Diagnosis (PGD) Total Revenue (USD Million) (2017-2018)
Table 68. Beijing Genomics Institute (BGI) SWOT Analysis
Table 69. Beijing Genomics Institute (BGI) Preimplantation Genetics Diagnosis (PGD) Product and Solutions
Table 70. Beijing Genomics Institute (BGI) Preimplantation Genetics Diagnosis (PGD) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Genea Limited Corporate Information, Location and Competitors
Table 72. Genea Limited Preimplantation Genetics Diagnosis (PGD) Major Business
Table 73. Genea Limited Preimplantation Genetics Diagnosis (PGD) Total Revenue (USD Million) (2017-2018)
Table 74. Genea Limited SWOT Analysis
Table 75. Genea Limited Preimplantation Genetics Diagnosis (PGD) Product and Solutions
Table 76. Genea Limited Preimplantation Genetics Diagnosis (PGD) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Global Preimplantation Genetics Diagnosis (PGD) Revenue (Million USD) by Players (2015-2020)
Table 78. Global Preimplantation Genetics Diagnosis (PGD) Revenue Share by Players (2015-2020)
Table 79. Global Preimplantation Genetics Diagnosis (PGD) Revenue (Million USD) by Regions (2015-2020)
Table 80. Global Preimplantation Genetics Diagnosis (PGD) Revenue Market Share by Regions (2015-2020)
Table 81. North America Preimplantation Genetics Diagnosis (PGD) Revenue by Countries (2015-2020)
Table 82. North America Preimplantation Genetics Diagnosis (PGD) Revenue Market Share by Countries (2015-2020)
Table 83. Europe Preimplantation Genetics Diagnosis (PGD) Revenue (Million USD) by Countries (2015-2020)
Table 84. Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Revenue (Million USD) by Countries (2015-2020)
Table 85. South America Preimplantation Genetics Diagnosis (PGD) Revenue by Countries (2015-2020)
Table 86. South America Preimplantation Genetics Diagnosis (PGD) Revenue Market Share by Countries (2015-2020)
Table 87. Middle East and Africa Preimplantation Genetics Diagnosis (PGD) Revenue (Million USD) by Countries (2015-2020)
Table 88. Middle East and Africa Preimplantation Genetics Diagnosis (PGD) Revenue Market Share by Countries (2015-2020)
Table 89. Global Preimplantation Genetics Diagnosis (PGD) Revenue (Million USD) by Type (2015-2020)
Table 90. Global Preimplantation Genetics Diagnosis (PGD) Revenue Share by Type (2015-2020)
Table 91. Global Preimplantation Genetics Diagnosis (PGD) Revenue Forecast by Type (2021-2025)
Table 92. Global Preimplantation Genetics Diagnosis (PGD) Revenue by Application (2015-2020)
Table 93. Global Preimplantation Genetics Diagnosis (PGD) Revenue Share by Application (2015-2020)
Table 94. Global Preimplantation Genetics Diagnosis (PGD) Revenue Forecast by Application (2021-2025)
Table 95. Global Preimplantation Genetics Diagnosis (PGD) Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Preimplantation Genetics Diagnosis (PGD) Picture
Figure 2. Global Preimplantation Genetics Diagnosis (PGD) Revenue Market Share by Type in 2019
Figure 3. Gender Selection Picture
Figure 4. Chromosomal Abnormalities Picture
Figure 5. Single Gene Disorders Picture
Figure 6. HLA Typing Picture
Figure 7. Aneuploidy Picture
Figure 8. X-Linked Diseases Picture
Figure 9. Other Picture
Figure 10. Preimplantation Genetics Diagnosis (PGD) Revenue Market Share by Application in 2019
Figure 11. Hospitals Picture
Figure 12. Clinics Picture
Figure 13. Other Picture
Figure 14. Global Preimplantation Genetics Diagnosis (PGD) Revenue (USD Million) and Growth Rate (2015-2025)
Figure 15. North America Preimplantation Genetics Diagnosis (PGD) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Europe Preimplantation Genetics Diagnosis (PGD) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. South America Preimplantation Genetics Diagnosis (PGD) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Middle East and Africa Preimplantation Genetics Diagnosis (PGD) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Global Preimplantation Genetics Diagnosis (PGD) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 21. Global Preimplantation Genetics Diagnosis (PGD) Revenue Share by Players in 2019
Figure 22. Global Top 5 Players Preimplantation Genetics Diagnosis (PGD) Revenue Market Share in 2019
Figure 23. Global Top 10 Players Preimplantation Genetics Diagnosis (PGD) Revenue Market Share in 2019
Figure 24. Key Players Market Share Trend
Figure 25. Global Preimplantation Genetics Diagnosis (PGD) Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 26. Global Preimplantation Genetics Diagnosis (PGD) Revenue Market Share by Regions (2015-2020)
Figure 27. Global Preimplantation Genetics Diagnosis (PGD) Revenue Market Share by Regions in 2018
Figure 28. North America Preimplantation Genetics Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
Figure 29. Europe Preimplantation Genetics Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
Figure 30. Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
Figure 31. South America Preimplantation Genetics Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
Figure 32. Middle East and Africa Preimplantation Genetics Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
Figure 33. North America Preimplantation Genetics Diagnosis (PGD) Revenue Market Share by Countries (2015-2020)
Figure 34. North America Preimplantation Genetics Diagnosis (PGD) Revenue Market Share by Countries in 2019
Figure 35. USA Preimplantation Genetics Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
Figure 36. Canada Preimplantation Genetics Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
Figure 37. Mexico Preimplantation Genetics Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
Figure 38. Europe Preimplantation Genetics Diagnosis (PGD) Revenue Market Share by Countries (2015-2020)
Figure 39. Europe Preimplantation Genetics Diagnosis (PGD) Revenue Market Share by Countries in 2019
Figure 40. Germany Preimplantation Genetics Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
Figure 41. UK Preimplantation Genetics Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
Figure 42. France Preimplantation Genetics Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
Figure 43. Russia Preimplantation Genetics Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
Figure 44. Italy Preimplantation Genetics Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
Figure 45. Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Revenue Market Share by Countries (2015-2020)
Figure 46. Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Revenue Market Share by Countries in 2019
Figure 47. China Preimplantation Genetics Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
Figure 48. Japan Preimplantation Genetics Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
Figure 49. Korea Preimplantation Genetics Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
Figure 50. India Preimplantation Genetics Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
Figure 51. Southeast Asia Preimplantation Genetics Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
Figure 52. South America Preimplantation Genetics Diagnosis (PGD) Revenue Market Share by Countries (2015-2020)
Figure 53. South America Preimplantation Genetics Diagnosis (PGD) Revenue Market Share by Countries in 2019
Figure 54. Brazil Preimplantation Genetics Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
Figure 55. Argentina Preimplantation Genetics Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
Figure 56. Middle East and Africa Preimplantation Genetics Diagnosis (PGD) Revenue Market Share by Countries (2015-2020)
Figure 57. Middle East and Africa Preimplantation Genetics Diagnosis (PGD) Revenue Market Share by Countries in 2019
Figure 58. Saudi Arabia Preimplantation Genetics Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
Figure 59. UAE Preimplantation Genetics Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
Figure 60. Egypt Preimplantation Genetics Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
Figure 61. South Africa Preimplantation Genetics Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
Figure 62. Global Preimplantation Genetics Diagnosis (PGD) Revenue Share by Type (2015-2020)
Figure 63. Global Preimplantation Genetics Diagnosis (PGD) Revenue Share by Type in 2019
Figure 64. Global Preimplantation Genetics Diagnosis (PGD) Market Share Forecast by Type (2021-2025)
Figure 65. Global Gender Selection Revenue Growth Rate (2015-2020)
Figure 66. Global Chromosomal Abnormalities Revenue Growth Rate (2015-2020)
Figure 67. Global Single Gene Disorders Revenue Growth Rate (2015-2020)
Figure 68. Global HLA Typing Revenue Growth Rate (2015-2020)
Figure 69. Global Aneuploidy Revenue Growth Rate (2015-2020)
Figure 70. Global X-Linked Diseases Revenue Growth Rate (2015-2020)
Figure 71. Global Other Revenue Growth Rate (2015-2020)
Figure 72. Global Preimplantation Genetics Diagnosis (PGD) Revenue Share by Application (2015-2020)
Figure 73. Global Preimplantation Genetics Diagnosis (PGD) Revenue Share by Application in 2019
Figure 74. Global Preimplantation Genetics Diagnosis (PGD) Market Share Forecast by Application (2021-2025)
Figure 75. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 76. Global Clinics Revenue Growth Rate (2015-2020)
Figure 77. Global Other Revenue Growth Rate (2015-2020)
Figure 78. Global Preimplantation Genetics Diagnosis (PGD) Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 79. Global Preimplantation Genetics Diagnosis (PGD) Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 80. Global Preimplantation Genetics Diagnosis (PGD) Revenue Market Share Forecast by Regions (2021-2025)
Figure 81. North America Preimplantation Genetics Diagnosis (PGD) Revenue Market Forecast (2021-2025)
Figure 82. Europe Preimplantation Genetics Diagnosis (PGD) Revenue Market Forecast (2021-2025)
Figure 83. Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Revenue Market Forecast (2021-2025)
Figure 84. South America Preimplantation Genetics Diagnosis (PGD) Revenue Market Forecast (2021-2025)
Figure 85. Middle East and Africa Preimplantation Genetics Diagnosis (PGD) Revenue Market Forecast (2021-2025)
Figure 86. Sales Channel: Direct Channel vs Indirect Channel
着床前遺伝子検査の世界市場（～2026年） Preimplantation genetic testing is a technique used to identify genetic defects in embryos created through in vitro fertilization (IVF) before pregnancy. Preimplantation genetic diagnosis (PGD) refers specifically to when one or both genetic parents has a known genetic abnormality and testing is per…- 肝炎検査診断の世界市場（～2026年） Hepatitis is generally classified into two types based on the duration for which the patient suffers. If the condition lasts for less than six months, then it is classified as acute, when the condition persists for more than six months, then it is a case of chronic condition. Hepatitis testing refer…
- 非侵襲的出生前診断の世界市場（～2026年） Noninvasive Prenatal Diagnostics detect a variety of chromosomal disorders such as Down's syndrome, Edwards syndrome, Turner syndrome and Pato syndrome. North America has the largest share of the noninvasive prenatal diagnostics market, with Asia Pacific and the Middle East achieving the fastest gro…
- 髄膜炎診断・治療の世界市場（～2026年） Meningitis is an acute inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges. The most common symptoms are fever, headache, and neck stiffness. Other symptoms include confusion or altered consciousness, vomiting, and an inability to tolerate …
- 胸膜炎診断の世界市場（～2026年） Pleurisy is the inflammation of the membrane known as pleura that surrounds the lungs inside the chest cavity. People suffering with pleurisy can experience chest pain while breathing. This disease is characterized by symptoms such as shortness of breath, cough, fever, and weight loss. Market Analys…